FWBI logo

First Wave BioPharma Inc

FWBI

$7.09

+ $2.10 (42.60%) This month

Closed: 4 Mar 2024 21:00 US/Eastern

Key details

CEO

James Sapirstein

Employees

12

Headquarters

Brooklyn, US

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

About First Wave BioPharma Inc

azurrx biopharma aims to become a leader in developing non-systemic, recombinant protein therapies for the treatment of gastrointestinal diseases and related conditions. ms1819 recombinant lipase for exocrine pancreatic insufficiency is the lead development program with additional early stage research being conducted for the prevention of hospital-acquired infection. the company is headquartered in new york, ny, with scientific operations based in langlade, france.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG